Mobile Cardiac Telemetry Patents: Who Leads, Where Filings Cooled 2026
- One assignee holds 29 of 96 records, and the top five combined account for 86.5% of all records in scope — a field concentrated at the very top.
- Filings peaked at 19 in 2021 and fell to 5 by 2024, a -74% drop over that three-year span, though 2025-26 figures are still filling in under normal publication lag.
- A61B diagnosis-and-surgery claims sit on 94.8% of all records, while G16H healthcare informatics and A61N electrotherapy each appear on a quarter of the field — signalling where software and signal-processing claims cluster.
Filing growth compares 2021 (19 records) with 2024 (5) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 96 records in scope (CR5), not by the ranked leaders only.
What the mobile cardiac telemetry patent record shows
Mobile cardiac telemetry sits at the intersection of ambulatory ECG hardware, wireless data transmission and the monitoring-centre workflows that triage alerts before a clinician sees them. The 96 records in scope, filed between 2015 and mid-2026, cluster overwhelmingly under diagnosis-and-surgery claims, with a meaningful secondary presence in digital data processing and electrotherapy classes. That pattern reflects a field where the core sensing and signal problem is heavily claimed, and where the newer contested ground is what happens to the data after it leaves the patch.
Filing activity rose through the late 2010s, peaked in 2021, and has declined since — a trend consistent with a technology that reached an early claiming rush and is now consolidating around a small number of established players rather than expanding its footprint.
Filing trend and technology composition
Two views of the same 96-record dataset: how filing activity has moved year over year, and which IPC subclasses carry the claim density.
Filing trend: a 2021 peak followed by a fall
Filings climbed from 6 in 2017 to a peak of 19 in 2021, then fell to 5 by 2024 — a -74% decline over that three-year span. Because publication lags filing by roughly 18 months, 2025 and 2026 figures are still incomplete and should not yet be read as a continued slide.
Where the claims sit
A61B (diagnosis and surgery) appears on 94.8% of all 96 records, confirming that ambulatory ECG sensing and signal acquisition remain the technical core. G06F, A61N and G16H each sit near a quarter of the field, marking software processing, electrotherapy integration and healthcare informatics as the active secondary fronts. A61H, G09B, A24D and B65D appear only in single digits, pointing to narrow, largely unclaimed adjacent uses.
Shares are the percentage of the 96 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Mobile Cardiac Telemetry Services with Eureka
This page is one run against one query. Ask Eureka your own question about mobile cardiac telemetry services and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited records in this dataset
US11103145B1 — Physiological signal monitoring and apparatus therefor
The patent covers an apparatus and method for monitoring vital signs, using a signal acquisition, digitization and computing module that removes noise, extracts diagnostically useful information, and compresses data to reduce data volume before a wireless communications circuit transmits it to a receiver.Filed by VivaQuant, Inc., granted 2021-08-31.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US8620418B1 | Systems and methods for processing and displaying patient electrocardiograph data | 172 |
| 2 | US20110270112A1 | Multi-Function Health Monitor | 163 |
| 3 | US8798734B2 | Systems and methods for processing and displaying patient electrocardiograph data | 145 |
| 4 | US20120259233A1 | Ambulatory physiological monitoring with remote analysis | 119 |
| 5 | US11083371B1 | Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of t… | 69 |
| 6 | US8972000B2 | Multi-function health monitor | 61 |
| 7 | US20160113520A1 | Multi-function health monitor | 50 |
| 8 | US20170164832A1 | Device Administered Tests and Adaptive Interactions | 47 |
| 9 | US10376172B2 | Systems and methods for classifying and displaying data | 41 |
| 10 | US20190282821A1 | Wearable medical device for continous heart monitoring with intermittent additional signal data provided via … | 36 |
Citation counts reflect influence within the searched corpus and favour older filings; treat them as a signal of prior-art weight, not current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for a filing or freedom-to-operate decision
Three read-outs from the concentration, trend and classification figures above.
The field is claimed by a small group, not a crowd
With the top five assignees accounting for 86.5% of all 96 records and the top ten reaching 97.9%, a new entrant is not filing into open ground — it is filing around a small number of incumbents who already hold the core sensing and workflow claims.
Filing activity has cooled from its 2021 peak
Filings rose to a peak of 19 in 2021 and fell to 5 by 2024, a -74% change over that span. That pattern is more consistent with claim consolidation around established players than with a technology still in an early land-grab phase.
Sensing is saturated; informatics is the open contest
A61B diagnosis-and-surgery claims cover nearly every record in scope, but G16H healthcare informatics and G06F data-processing classes sit at roughly a quarter each — the alert-triage, workflow and reimbursement-adjacent software layers are far less densely claimed than the sensor hardware itself.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to mobile cardiac telemetry services, with the prior art for and against each one.
Who holds the claim space
The ranked leaders here cover 15 companies returned by the data endpoint — not a top-50 or top-100 cut, the full list the dataset produces for this search.
A single assignee holds nearly a third of the field
The leading assignee's 29 records, against a field of 96, sets the baseline any freedom-to-operate review has to clear first — its portfolio anchors the top of a ranking where the fifth-placed company holds only 3.
A steep drop after the top few names
Filing counts fall from 29 at the top to 3 by fifth place and 2 by tenth, showing a long tail of entrants with one or two filings each rather than a broad middle tier of active challengers.
Co-filing is rare in this field
Only five co-assignee pairs appear across 96 records, and the strongest pairings involve two filings at most — this is a field of largely independent filers rather than joint-development programmes.
| Assignee | Recent year | YoY |
|---|---|---|
| Applied Cardiac Systems Inc | 0 | — |
| ZOLL Medical Corporation | 0 | -100% |
| APPLIED CARDIAC SYSTEMS INC | 0 | — |
| InfoBionic Inc | 0 | — |
| PARALE GURUNATH PURUSHOTTAM | 0 | — |
| Preventice Solutions Inc | 0 | — |
| Arrhythmia Research Technology Inc | 0 | — |
| VIVAQUANT LLC | 0 | — |
Where to take this analysis
The figures above establish the shape of the field; the next steps depend on whether the goal is filing, licensing or freedom-to-operate clearance.
Map claims against the leader's 29-record portfolio
Before drafting new claims in sensing or signal acquisition, check them against the top assignee's filings — that portfolio anchors the densest part of the A61B classification.
Explore assignee portfolios in EurekaTest the informatics and triage white space
G16H and G06F sit at roughly a quarter of records each, well below A61B's near-total coverage — this is where a narrowly drafted claim on triage or compliance workflows may still find open ground.
Run a white space search in EurekaTrack filings past the 2024 cut-off
Because publication lags filing by around 18 months, 2025 and 2026 counts will keep revising upward — recheck the trend before concluding the field has genuinely slowed.
Set up filing alerts in EurekaCommon questions about mobile cardiac telemetry patents
One assignee leads the ranked list with 29 of the 96 records in scope, well ahead of the rest of the field. The top five assignees combined account for 86.5% of all records, and the top ten reach 97.9%, so the field is concentrated among a small number of established players rather than spread across many active filers. Anyone assessing freedom to operate should start with that leading portfolio before looking further down the ranking.
Filings rose through the late 2010s and peaked at 19 in 2021, then fell to 5 by 2024 — a -74% decline over that three-year span. That drop reflects genuine consolidation in complete-year data, but 2025 and 2026 figures are still incomplete because publication typically lags filing by about 18 months. The safest reading is that the initial claiming rush has passed, not that new filing has stopped entirely.
Nearly all records, 94.8% of the 96 in scope, carry an A61B classification covering diagnosis and surgical monitoring equipment, which is the technical core of ambulatory ECG sensing. Secondary classes include G06F (digital data processing), A61N (electrotherapy) and G16H (healthcare informatics), each appearing on about a quarter of records, marking the software and workflow layers as the more actively contested secondary ground. Narrower classes like A61H, G09B, A24D and B65D appear on only a handful of records each.
The sensing and signal-acquisition core under A61B is heavily claimed, but workflow-adjacent areas — alert-triage automation, reimbursement-code data tagging, patient-compliance analytics, technician workload balancing and notification-latency reduction — show much thinner filing density relative to that core. These are the branches named in the search query itself but not yet densely claimed in the granted patent record. A first claim there would likely need to tie a specific data-processing step to one of these operational outcomes rather than to the sensing hardware itself.
US11103145B1, assigned to VivaQuant, Inc. and granted in 2021, covers an apparatus and method for monitoring vital signs that acquires and digitises a physiological signal, removes noise, extracts diagnostically useful information, compresses the data to reduce data volume, and transmits it wirelessly to a receiver. That combination of on-device noise reduction, feature extraction and data compression ahead of wireless transmission is the specific technical chain the claims protect. Anyone designing a competing device should check whether their own signal pipeline performs the same sequence of steps before assuming it falls outside this patent's scope.
Research Mobile Cardiac Telemetry Services in depth with Eureka
Go past this page: query the whole mobile cardiac telemetry services corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.